2000
DOI: 10.3892/ijmm.5.4.389
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-10 expression in intestine of Crohn disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 0 publications
0
13
0
Order By: Relevance
“…Therefore, deficiency or dysregulated expression of IL-10 production is often a main cause of autoimmune diseases or exaggerated inflammatory responses. IL-10-deficient mice as well as patients with Crohn's disease display severe chronic enterocolitis, in which the up-regulation of inflammatory cytokines such as IFN-␥, IL-12, TNF-␣, IL-1, and IL-18 is observed, demonstrating the protective role of IL-10 in inflammatory conditions (35). Systemic lupus erythematosus is associated with the high production of IL-10, which leads to impaired T cell responses and dysregulation of B cell activation (36).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, deficiency or dysregulated expression of IL-10 production is often a main cause of autoimmune diseases or exaggerated inflammatory responses. IL-10-deficient mice as well as patients with Crohn's disease display severe chronic enterocolitis, in which the up-regulation of inflammatory cytokines such as IFN-␥, IL-12, TNF-␣, IL-1, and IL-18 is observed, demonstrating the protective role of IL-10 in inflammatory conditions (35). Systemic lupus erythematosus is associated with the high production of IL-10, which leads to impaired T cell responses and dysregulation of B cell activation (36).…”
Section: Discussionmentioning
confidence: 99%
“…It is believed that IL-10 plays an important role in the functioning of regulatory T cells that control inflammatory responses towards intestinal antigens [3] and the dysregulation of IL-10 is connected with inflammatory bowel disease [1,13]. IL-10 and IL-1 display opposite effects, the former being an inhibitor of IL-1 synthesis by macrophages.…”
Section: Discussionmentioning
confidence: 99%
“…IL-10 has anti-inflammatory effects on proinflammatory cytokines (IL-1, IL-6, TNF-α) and its mucosal levels were found increased both in CD and UC (Akagi et al, 2000;Olsen et al, 2007) (for review see (Kaser et al, 2010)) except for a single study (Nielsen et al, 1996). Of interest, mucosal levels of IL-10 and IL-4 in UC did not correlate with the treatment effects of infliximab (Olsen et al, 2009) and were not found reduced after infliximab treatment (Agnholt et al, 2003).…”
Section: Il-10mentioning
confidence: 99%